BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28408351)

  • 1. Inhibition of heat shock protein 90 rescues glucocorticoid-induced bone loss through enhancing bone formation.
    Chen H; Xing J; Hu X; Chen L; Lv H; Xu C; Hong D; Wu X
    J Steroid Biochem Mol Biol; 2017 Jul; 171():236-246. PubMed ID: 28408351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strontium gluconate potently promotes osteoblast development and restores bone formation in glucocorticoid-induced osteoporosis rats.
    Dai L; Chen X; Xiong Y; Chen J; Li J; Li D; Zhou G; Zou Y; Liu T
    Biochem Biophys Res Commun; 2021 May; 554():33-40. PubMed ID: 33774277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular stress-inducing compounds increase osteoclast formation in a heat shock factor 1 protein-dependent manner.
    Chai RC; Kouspou MM; Lang BJ; Nguyen CH; van der Kraan AG; Vieusseux JL; Lim RC; Gillespie MT; Benjamin IJ; Quinn JM; Price JT
    J Biol Chem; 2014 May; 289(19):13602-14. PubMed ID: 24692538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HSP90 inhibitors enhance differentiation and MITF (microphthalmia transcription factor) activity in osteoclast progenitors.
    van der Kraan AG; Chai RC; Singh PP; Lang BJ; Xu J; Gillespie MT; Price JT; Quinn JM
    Biochem J; 2013 Apr; 451(2):235-44. PubMed ID: 23379601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity.
    Conaway HH; Henning P; Lie A; Tuckermann J; Lerner UH
    Bone; 2016 Dec; 93():43-54. PubMed ID: 27596806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Let-7f-5p regulates TGFBR1 in glucocorticoid-inhibited osteoblast differentiation and ameliorates glucocorticoid-induced bone loss.
    Shen GY; Ren H; Shang Q; Zhao WH; Zhang ZD; Yu X; Huang JJ; Tang JJ; Yang ZD; Liang D; Jiang XB
    Int J Biol Sci; 2019; 15(10):2182-2197. PubMed ID: 31592234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HSP90β chaperoning SMURF1-mediated LATS proteasomal degradation in the regulation of bone formation.
    Qu M; Gong Y; Jin Y; Gao R; He Q; Xu Y; Shen T; Mei L; Xu C; Hussain M; Barkat MQ; Wu X
    Cell Signal; 2023 Feb; 102():110523. PubMed ID: 36379376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginsenosides Rg3 attenuates glucocorticoid-induced osteoporosis through regulating BMP-2/BMPR1A/Runx2 signaling pathway.
    Zhang X; Chen K; Wei B; Liu X; Lei Z; Bai X
    Chem Biol Interact; 2016 Aug; 256():188-97. PubMed ID: 27387537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of iguratimod on glucocorticoid-induced disorder of bone metabolism in vitro.
    Miyama A; Ebina K; Hirao M; Okamura G; Etani Y; Takami K; Goshima A; Miura T; Oyama S; Kanamoto T; Yoshikawa H; Nakata K
    J Bone Miner Metab; 2021 Jul; 39(4):639-648. PubMed ID: 33564917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dicer ablation in osteoblasts by Runx2 driven cre-loxP recombination affects bone integrity, but not glucocorticoid-induced suppression of bone formation.
    Liu P; Baumgart M; Groth M; Wittmann J; Jäck HM; Platzer M; Tuckermann JP; Baschant U
    Sci Rep; 2016 Aug; 6():32112. PubMed ID: 27554624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid receptor and Histone deacetylase 6 mediate the differential effect of dexamethasone during osteogenesis of mesenchymal stromal cells (MSCs).
    Rimando MG; Wu HH; Liu YA; Lee CW; Kuo SW; Lo YP; Tseng KF; Liu YS; Lee OK
    Sci Rep; 2016 Nov; 6():37371. PubMed ID: 27901049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line.
    Price JT; Quinn JM; Sims NA; Vieusseux J; Waldeck K; Docherty SE; Myers D; Nakamura A; Waltham MC; Gillespie MT; Thompson EW
    Cancer Res; 2005 Jun; 65(11):4929-38. PubMed ID: 15930315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone enhances osteoclast formation synergistically with transforming growth factor-beta by stimulating the priming of osteoclast progenitors for differentiation into osteoclasts.
    Takuma A; Kaneda T; Sato T; Ninomiya S; Kumegawa M; Hakeda Y
    J Biol Chem; 2003 Nov; 278(45):44667-74. PubMed ID: 12944401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 11β-Hydroxysteroid dehydrogenase type 1 selective inhibitor BVT.2733 protects osteoblasts against endogenous glucocorticoid induced dysfunction.
    Wu L; Qi H; Zhong Y; Lv S; Yu J; Liu J; Wang L; Bi J; Kong X; Di W; Zha J; Liu F; Ding G
    Endocr J; 2013; 60(9):1047-58. PubMed ID: 23759754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing miR-106b accelerates osteogenesis of mesenchymal stem cells and rescues against glucocorticoid-induced osteoporosis by targeting BMP2.
    Liu K; Jing Y; Zhang W; Fu X; Zhao H; Zhou X; Tao Y; Yang H; Zhang Y; Zen K; Zhang C; Li D; Shi Q
    Bone; 2017 Apr; 97():130-138. PubMed ID: 28108317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrodin protects MC3T3-E1 osteoblasts from dexamethasone-induced cellular dysfunction and promotes bone formation via induction of the NRF2 signaling pathway.
    Liu S; Fang T; Yang L; Chen Z; Mu S; Fu Q
    Int J Mol Med; 2018 Apr; 41(4):2059-2069. PubMed ID: 29393365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoids suppress Wnt16 expression in osteoblasts in vitro and in vivo.
    Hildebrandt S; Baschant U; Thiele S; Tuckermann J; Hofbauer LC; Rauner M
    Sci Rep; 2018 Jun; 8(1):8711. PubMed ID: 29880826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of the glucocorticoid receptor subcellular localization by non steroidal compounds.
    Prima V; Depoix C; Masselot B; Formstecher P; Lefebvre P
    J Steroid Biochem Mol Biol; 2000; 72(1-2):1-12. PubMed ID: 10731632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of glucocorticoid-induced osteoporosis.
    Canalis E
    Curr Opin Rheumatol; 2003 Jul; 15(4):454-7. PubMed ID: 12819474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 11β-HSD1 plays a critical role in trabecular bone loss associated with systemic glucocorticoid therapy.
    Fenton CG; Doig CL; Fareed S; Naylor A; Morrell AP; Addison O; Wehmeyer C; Buckley CD; Cooper MS; Lavery GG; Raza K; Hardy RS
    Arthritis Res Ther; 2019 Aug; 21(1):188. PubMed ID: 31420008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.